Bone Resorption Inhibitors [Bone Metabolism Research] — compiles bisphosphonate compounds such as zoledronate, alendronate, ibandronate, minodronate, and risedronate, which structurally resemble pyrophosphate and are therefore widely studied in bone metabolism research, in osteoclast cell activity, and in the mineral matrix remodeling process of bone.
These bisphosphonate compounds are used by bone metabolism researchers to study the mechanisms of bone resorption inhibition by osteoclasts and the biochemical pathways of farnesyl pyrophosphate synthase involved in it. Sodium salt and hydrate forms such as alendronate sodium trihydrate and risedronate monosodium hemipentahydrate are often used in in vitro studies and animal models related to bone mineral density.
Example products in this collection: TCI Z0031 165800-06-6 Zoledronic Acid Monohydrate, TCI C3597 47931-85-1 Calcitonin Salmon, TCI A2456 121268-17-5 Alendronate Sodium Trihydrate, TCI D3921 57248-88-1 Disodium Pamidronate, TCI A2120 66376-36-1 Alendronic Acid, TCI D4159 7414-83-7 Disodium Etidronate Hydrate, TCI S0877 138844-81-2 Sodium Ibandronate, TCI D4160 88416-50-6 Disodium Clodronate Tetrahydrate.
Pay attention to the hydrate or salt form (sodium, monohydrate, trihydrate) and the purity level of each bisphosphonate, as these variations affect solubility and the consistency of results in bone metabolism research protocols. All products are genuine Tokyo Chemical Industry (TCI) Japan products, with purity, packaging, and storage conditions listed on each item's page.
Other parallel categories under Bone Metabolism Research, often used together in one laboratory workflow:
Back to Bone Metabolism Research. For large-volume procurement, special packaging, or specific grades, contact the AMI Scientific team, the official TCI Japan distributor in Indonesia, for availability checks and lead time directly from Japan.
